{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Taylor K"],"funding":["British Heart Foundation","UKRI Medical Research Council","Medical Research Council","Diabetes UK","National Institute for Health and Care Research","Wellcome Trust"],"pagination":["558-568"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617111"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(8)"],"pubmed_abstract":["<h4>Background</h4>Some studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19 vaccination, up to 52 weeks after diagnosis.<h4>Methods</h4>In this retrospective cohort study, we investigated the diagnoses of incident diabetes following COVID-19 diagnosis in England in a pre-vaccination, vaccinated, and unvaccinated cohort using linked electronic health records. People alive and aged between 18 years and 110 years, registered with a "],"journal":["The lancet. Diabetes & endocrinology"],"pubmed_title":["Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people."],"pmcid":["PMC7617111"],"funding_grant_id":["RG/13/13/30194","RE/18/1/34212","MC_PC_20059","RG/18/13/33946"],"pubmed_authors":["Douglas I","Finnigan L","Cowling T","Ploubidis G","Maddock J","Greaves F","Williams D","Fang C","Badrick E","Goldacre B","Taylor K","Wielgoszewska B","Fox L","Rhead R","Nigrelli L","Stewart C","Lukaschuk E","Wright J","Horne EMF","Parsons S","Smeeth L","Patel K","Steves C","Bridger-Staatz C","Campbell KC","Turner EL","Nab L","McEachan R","Hughes A","Freydin M","Sterne J","Hopcroft LEM","Forbes H","OpenSAFELY collaborative","Walker V","Booth C","Chaturvedi N","McCartney D","Shah SA","CONVALESCENCE study","Walter S","Carpentieri J","Sampri A","Stafford J","Fisher L","Gibson A","Timpson N","Knueppel A","Carnemolla A","Longitudinal Health and Wellbeing and Data and Connectivity UK COVID-19 National Core Studies","Kanagaratnam A","Perez-Reche F","Oakley J","Sheard L","Hamill Howes L","Andrews C","Massey J","Bolton T","Cuitun Coronado JI","Sheikh A","Flaig R","Lemanska A","Wei Y","Hamilton O","Goncalves Soares A","Huntley L","Zaninotto P","Shaw R","Thomas R","Willan K","Wong A","Di Gessa G","Macleod J","McElroy E","Glen F","Cuitun Coronado J","Ferreira V","Woodward H","Curtis H","Morley J","Horne E","Karthikeyan Suseeladevi A","Almaghrabi F","Green A","Berman S","Herrett E","McLachlan S","Eastwood S","Mitchell R","Morton C","Wood A","Folarin A","Piehlmaier D","Kellas J","Knight R","Green M","Willans R","Beckford C","Evans KM","Zhu J","Roberts A","Cheetham N","Whitehorn R","Raman B","Crane M","Sanders ZB","Kromydas T","Denaxas S","Piechnik S","Langan S","Brophy S","Thompson E","Wang K","Tunnicliffe E","Parker M","Costello R","Ip S","Rafeti E","Santorelli G","Katikireddi V","Kibble M","Denholm R","Teece L","Baz S","Hulme W","Hopcroft L","Silverwood R","Saunders LC","Boyd A","Foster D","Kwong A","Garcia P","Wild JM","Mackenna B","Jones L","Moltrecht B","Steptoe A","Yang T","Griffith G","Park C","Davy S","McArdle F","Dillingham I","Tazare J","Tomlinson L","Al Arab M","Rapala A","Mahalingasivam V","Sharp S","North T","Toms R","Walker A","Zheng B","Herbet A","Jezzard P","Mansfield K","Kennedy JI","Kopasker D","Northstone K","Jacques W","Bowyer R","Ranjan Y","Palmer T","Dobson R","Neubauer S","Tilling K","Sterne JAC","Shah A","Smith S","Campbell A","Hou B","Patalay P","Cezard G"],"additional_accession":[]},"is_claimable":false,"name":"Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people.","description":"<h4>Background</h4>Some studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19 vaccination, up to 52 weeks after diagnosis.<h4>Methods</h4>In this retrospective cohort study, we investigated the diagnoses of incident diabetes following COVID-19 diagnosis in England in a pre-vaccination, vaccinated, and unvaccinated cohort using linked electronic health records. People alive and aged between 18 years and 110 years, registered with a ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2025-04-03T23:55:44.937Z","creation":"2025-04-03T23:55:44.937Z"},"accession":"S-EPMC7617111","cross_references":{"pubmed":["39054034"],"doi":["10.1016/S2213-8587(24)00159-1"]}}